A Novel Phenylaminotetralin Radioligand Reveals a Subpopulation of Histamine H1 Receptors
Authors:
- Raymond G. BoothRBRaymond G. Booth
- Nader H. MoniriNMNader H. Moniri
- Remko A. BakkerRBRemko A. Bakker
- Neepa Y. ChoksiNCNeepa Y. Choksi
- William B. NixWNWilliam B. Nix
- Henk TimmermanHTHenk Timmerman
- Rob LeursRLRob Leurs
- 1 July 2002
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 302 (1) , 328-336
Abstract
Previously, (−)-trans-1-phenyl-3-N,N-dimethylamino-1,2,3,4-tetrahydronaphthalene ([−]-trans-H2-PAT) was shown to activate stereospecifically histamine H1 receptors coupled to modulation of tyrosine hydroxylase activity in guinea pig and rat forebrain in vitro and in vivo. Furthermore, the novel radioligand [3H](−)-trans-H2-PAT was shown to label selectively H1 receptors in guinea pig and rat brain with high affinity (KD, ∼0.1 and 0.5 nM, respectively) and a Bmax about 50 and 15%, respectively, of that observed for the H1antagonist radioligand [3H]mepyramine. In the current study, [3H](−)-trans-H2-PAT-labeled cloned guinea pig and human H1 receptors in Chinese hamster ovary (CHO) cell membranes with high affinity (KD, ∼0.08 and 0.23 nM, respectively) and a Bmax about 15% of that observed for [3H]mepyramine. The binding of H2-PAT to H1 receptors in both CHO-H1 cell lines was stereoselective with the (−)-trans-isomer having affinity (Ki, ∼1.5 nM) about 4-, 20-, and 50-times higher than the (−)-cis-, (+)-trans-, and (+)-cis-isomers, respectively; the affinity of (−)-trans-H2-PAT was unaffected by excess GTP. In functional assays, (−)-trans-H2-PAT was a full antagonist of histamine H1-mediated stimulation of phospholipase C (PLC) and [3H]inositol phosphates (IP) formation in CHO-H1 cells, a full inverse agonist of constitutively active H1 receptors in COS-7-H1cells, and a full competitive antagonist (pA2 = 9.2) of histamine H1-mediated contraction of guinea pig ileum. It is concluded that (−)-trans-H2-PAT is an antagonist at H1 receptors coupled to PLC/IP formation and smooth muscle contraction. Meanwhile, the observation that [3H](−)-trans-H2-PAT labels only a subpopulation of H1 receptors and that (−)-trans-H2-PAT activates H1receptors coupled to modulation of tyrosine hydroxylase suggests that there may be post-translational H1 receptor heterogeneity.Keywords
This publication has 36 references indexed in Scilit:
- Histamine H1-Receptor Activation of Nuclear Factor-κB: Roles for Gβγ- and Gαq/11-Subunits in Constitutive and Agonist-Mediated SignalingMolecular Pharmacology, 2001
- Constitutive activity of the histamine H1 receptor reveals inverse agonism of histamine H1 receptor antagonistsEuropean Journal of Pharmacology, 2000
- A novel phenylaminotetralin (PAT) recognizes histamine H1 receptors and stimulates dopamine synthesis in vivo in rat brainBrain Research, 1999
- Putative σ3 sites in mammalian brain have histamine H1 receptor properties: evidence from ligand binding and distribution studies with the novel H1 radioligand []-(−)-trans-1-phenyl-3-aminotetralinBrain Research, 1999
- Dimerization of the δ Opioid Receptor:Journal of Biological Chemistry, 1997
- Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells1FEBS Letters, 1997
- 8,9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: A Potent Full Dopamine D1 Agonist Containing a Rigid β-Phenyldopamine PharmacophoreJournal of Medicinal Chemistry, 1996
- Histamine H1‐Receptor Binding Sites in Guinea Pig Brain Membranes: Regulation of Agonist Interactions by Guanine Nucleotides and CationsJournal of Neurochemistry, 1980
- HETEROGENEITY OF HISTAMINE Hi‐RECEPTORS: SPECIES VARIATIONS IN [3H]MEPYRAMINE BINDING OF BRAIN MEMBRANESJournal of Neurochemistry, 1979
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973